Announcements
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
- IGM Biosciences Announces Third Quarter 2023 Financial Results
- IGM Biosciences to Present at Two Upcoming Investor Conferences
- IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors
- IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
More ▼
Key statistics
As of last trade, IGM Biosciences Inc (1K0:FRA) traded at 6.90, 87.50% above the 52 week low of 3.68 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.90 |
---|---|
High | 6.90 |
Low | 6.90 |
Bid | 6.65 |
Offer | 6.70 |
Previous close | 7.30 |
Average volume | 12.67 |
---|---|
Shares outstanding | 58.79m |
Free float | 21.56m |
P/E (TTM) | -- |
Market cap | 435.61m USD |
EPS (TTM) | -4.81 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 14:50 BST.
More ▼